LETTER TO THE EDITOR
Year : 2021 | Volume
: 32 | Issue : 2 | Page : 586--587
Comment on “Knowledge and attitude toward organ donation among medical staff and outpatients at king abdulaziz medical city, Riyadh, Saudi Arabia”
Department of Allied Health Sciences, College of Medicine and Health Sciences, Sultan Qaboos University, P. O. Box 35 Postal Code 123, Muscat, Oman
Department of Allied Health Sciences, College of Medicine and Health Sciences, Sultan Qaboos University, P. O. Box 35 Postal Code 123, Muscat
|How to cite this article:|
Alwahaibi N. Comment on “Knowledge and attitude toward organ donation among medical staff and outpatients at king abdulaziz medical city, Riyadh, Saudi Arabia”.Saudi J Kidney Dis Transpl 2021;32:586-587
|How to cite this URL:|
Alwahaibi N. Comment on “Knowledge and attitude toward organ donation among medical staff and outpatients at king abdulaziz medical city, Riyadh, Saudi Arabia”. Saudi J Kidney Dis Transpl [serial online] 2021 [cited 2022 May 23 ];32:586-587
Available from: https://www.sjkdt.org/text.asp?2021/32/2/586/335477
To the Editor,
I read with great interest the study published by Dr. Altraif and his team. They measured the knowledge and attitude among health-care professionals and the public toward organ donation in Saudi Arabia. They found that 97.6% of the participants knew about the concept of organ donation and 96% support promoting organ donation. Here, I would like to draw attention to the coronavirus disease 2019 (COVID-19) pandemic and its effects on organ donation and subsequent reduction in transplantation rate.
COVID-19, which was first described by Wuhan Municipal Health Commission in China on 31 December 2019, is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). As on February 9, 2021, COVID-19 has caused 107,006,667 confirmed total cases and 2,336,303 deaths in 219 countries and territories over six continents. The number is still on the rise. Organ transplant recipients are likely to be at an increased risk of problems from COVID-19. In addition, most of these recipients have at least other cofactors such as hypertension, diabetes mellitus, cardiovascular disease, chronic lung disease, and obesity.
The COVID-19 pandemic has globally affected the health-care systems, economy, research implications, food and other material productions, electricity consumption, travel, and tourism due to restrictions on them and even usual life and much more. Organ transplantation has no exemption from the COVID-19, during the pandemic; the number of organ donors has dropped globally. For example, in France, kidney donors dropped by 90.6%, and in the United States, it dropped by 51.1%. Subsequently, many transplant procedures, mainly kidney transplantation, have been reduced by up to 80%., It is also important to note that transplant procedure is in fact risky to the surgeons and nurses as possible transmission of the SARS-CoV-2. Worldwide, several countries reported various high mortality rates mainly among kidney transplant recipients. For example, the mortality rates were 39%, 32%, 25%, 23%, 12.5%, and 10% in the United States, Spain, Italy, France, Turkey, and China, respectively.,,,,,
Kidney transplantation can be temporarily postponed during the COVID-19 pandemic as renal dialysis can continue to support life. However, patients needing heart and lung transplantations cannot wait for prolonged time, as their lives might be lost. Thus, these transplantations should be undertaken with strict precautionary procedures for donors, recipients, surgeons, nurses, and other staff during the time of organ transplantation rather than postponement of a lifesaving procedure.
Conflict of interest: None declared.
|1||Altraif I, Altuwaijri N, Aldhbiban L, et al. Knowledge and attitude toward organ donation among medical staff and outpatients at King Abdulaziz Medical City, Riyadh, Saudi Arabia. Saudi J Kidney Dis Transpl 2020;31: 1344-50.|
|2||World Population Clock - Worldometer (2021). Available: https://www.worldometers. info/world-population. [Last accessed on 2021 Feb 09].|
|3||Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and solid organ transplanttation: A review article. Transplantation 2021;105:37-55.|
|4||Loupy A, Aubert O, Reese PP, Bastien O, Bayer F, Jacquelinet C. Organ procurement and transplantation during the COVID-19 pandemic. Lancet 2020;395:e95-6.|
|5||Domínguez-Gil B, Coll E, Fernández-Ruiz M, et al. COVID-19 in Spain: Transplantation in the midst of the pandemic. Am J Transplant 2020;20:2593-8.|
|6||Angelico R, Trapani S, Manzia TM, Lombardini L, Tisone G, Cardillo M. The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs. Am J Transplant 2020;20:1780-4.|
|7||Hartzell S, Bin S, Benedetti C, et al. Evidence of potent humoral immune activity in COVID-19- infected kidney transplant recipients. Am J Transplant 2020;20:3149-61.|
|8||Cravedi P, Mothi SS, Azzi Y, et al. COVID-19 and kidney transplantation: Results from the TANGO international transplant consortium. Am J Transplant 2020;20:3140-8.|
|9||Alberici F, Delbarba E, Manenti C, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int 2020;98:20-6.|
|10||Caillard S, Anglicheau D, Matignon M, et al. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020;98:1549-58.|
|11||Demir E, Uyar M, Parmaksiz E, et al. COVID-19 in kidney transplant recipients: A multi-center experience in Istanbul. Transpl Infect Dis 2020;22:e13371.|
|12||Zhu L, Gong N, Liu B, et al. Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: A summary of 10 confirmed cases in Wuhan, China. Eur Urol 2020;77:748-54.|